Cellebrite (CLBTW) details Q2 2025 results and appoints Thomas E. Hogan CEO

Rhea-AI Filing Summary

Cellebrite DI Ltd. furnished a report stating it issued a press release titled “Cellebrite Announces Second-Quarter 2025 Results; Thomas E. Hogan Named CEO.” The company highlights that GAAP financial statement tables from this press release are incorporated by reference into its existing Form S-8 and Form F-3 registration statements.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of August 2025

Commission File Number 001-40772

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

On August 14, 2025, Cellebrite DI Ltd. (the “Registrant” or “Cellebrite”) issued a press release titled “Cellebrite Announces Second-Quarter 2025 Results; Thomas E. Hogan Named CEO.” A copy of this press release is furnished as Exhibit 99.1 herewith.

The GAAP financial statements tables contained in the press release attached to this report on Form 6-K are incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.

1

EXHIBIT INDEX

Exhibit		Description
99.1		Press release titled “Cellebrite Announces Second-Quarter 2025 Results; Thomas E. Hogan Named CEO” (furnished herewith).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellebrite DI Ltd.
August 14, 2025	By:	/s/ David Barter
		David Barter
		Chief Financial Officer

3

FAQ

What does Cellebrite (CLBTW) disclose in its August 2025 6-K filing?

The filing notes that Cellebrite issued a press release titled “Cellebrite Announces Second-Quarter 2025 Results; Thomas E. Hogan Named CEO.” It also explains that GAAP financial tables from this release are incorporated into existing S-8 and F-3 registration statements.

Who was named CEO of Cellebrite (CLBTW) in the referenced announcement?

The filing states that Thomas E. Hogan was named CEO of Cellebrite in a press release dated August 14, 2025. That release is attached as Exhibit 99.1 and includes the company’s second-quarter 2025 results and related GAAP financial tables.

How are Cellebrite’s GAAP financial tables used in this 6-K filing?

The 6-K explains that GAAP financial statement tables in the attached press release are incorporated by reference into Cellebrite’s registration statements on Form S-8 and Form F-3. This links the latest quarterly financials directly to those existing registration documents.

Which Cellebrite registration statements are updated by this 6-K filing?

The report specifies that the GAAP tables are incorporated into Form S-8 registration statements with file numbers 333-260878 and 333-278130, and a Form F-3 registration statement with file number 333-259826. These filings remain effective with updated financial information attached.

What exhibit is attached to Cellebrite’s August 2025 6-K filing?

The filing attaches Exhibit 99.1, a press release titled “Cellebrite Announces Second-Quarter 2025 Results; Thomas E. Hogan Named CEO.” This exhibit contains the company’s second-quarter 2025 financial information presented under GAAP and details about the leadership change.